Maximising data capture in obesity trials
ICON's imaging strategy against 'silent attrition'
In Association With ICON Biotech
Meet critical milestones
The impact of drug pricing and reimbursement on the pharmaceutical industry
Obesity therapies and the multi-indication momentum: how industry is responding
Obesity-related liver conditions: Understanding treatment options
How CNS researchers are handling clinical trial turbulence
Immunotherapeutic responses and their assessments
Designing clinical trials for a complex disease: pediatric obesity
Oncology R&D: emerging therapies and new challenges
